In patients with severe circulatory compromise, enteral nutrition (EN) is usually considered hazardous as it may aggravate gut ischemia. However, the available evidence supporting this hypothesis is scarce and contradictory. We describe our experience with early EN in 37 critically ill post-cardiac surgery patients with hemodynamic failure. Under proper medical supervision, early EN emerged as feasible and safe. An intervention clinical trial is needed to confirm these findings.
Introduction
Most patients undergoing cardiac surgery do not require nutrition therapy since they are able to resume oral feeding within 2-3 days. However, in some of these patients, the postoperative course is more complicated, and prolonged mechanical ventilation, as well as vasoactive drugs and/or mechanical support, is needed as a consequence of hemodynamic failure. These patients are often hypercatabolic and are unable to ingest food for 5-7 days, thus increasing the risk of malnutrition. In critically ill patients, this situation has been linked to several possible complications, prolonging hospital stay and elevating healthcare costs. [1] [2] [3] [4] In critically ill mechanically ventilated patients, particularly the sickest patients, early enteral nutrition (EN) has been correlated with reductions in intensive care unit (ICU) and 4219P ENXXX10.1177/0148607113504219Journal of Parenteral and Enteral NutritionFlordelís Lasierra et al 013 From the 1 hospital mortality, 5 hospital stay, and infectious complications. 6, 7 Nevertheless, EN is often contraindicated and is even considered dangerous in patients with circulatory failure. Hemodynamic instability affects the splanchnic circulation, reducing splanchnic flow relative to cardiac output, and this, in turn, increases the risk of splanchnic ischemia. 8 Reported rates of acute mesenteric ischemia following cardiac surgery are 0.5%−1.4%, and mortality attributed to this complication is in the range of 11%−27%. 9, 10 Current guidelines issued by the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) and European Society for Clinical Nutrition and Metabolism (ESPEN) 11, 12 state that EN should be withheld in patients with circulatory compromise until they are fully resuscitated and/or hemodynamically stable. These recommendations are based on the results of nonrandomized trials, studies using retrospective control data, the findings of several uncontrolled studies examining case series, and expert opinions. However, several experimental animal models [13] [14] [15] [16] [17] have indicated that EN may be possible despite hemodynamic failure and may even improve splanchnic perfusion and reduce bacterial translocation. Moreover, following cardiac surgery, the gut appears to remain functional even when there is circulatory failure. 18 In addition, the results of 3 studies have indicated that EN may be safe in these patients under close clinical monitoring. [19] [20] [21] More recently, a study conducted in patients with severe respiratory and hemodynamic failure requiring extracorporeal membrane oxygenation (ECMO) has highlighted the feasibility of EN in these patients. 22 Following cardiac surgery, patients in the ICU of our center routinely receive EN therapy. However, despite growing evidence in favor of early EN in these patients, to date, few prospective studies have addressed this issue, and the decision to initiate early EN in patients with circulatory compromise after cardiac surgery remains controversial. 23, 24 The present study was designed to examine the feasibility and efficacy of EN support and its associated complications in cardiac surgery patients with hemodynamic failure.
Methods
In a prospective observational study performed at our postcardiac surgery ICU, we recruited cardiac surgery patients with hemodynamic failure subjected to at least 24 hours of mechanical ventilation.
Hemodynamic failure was defined as dependence on 2 or more vasoactive drugs and/or mechanical support such as intra-aortic balloon pump (IABP), mechanical circulatory assistance, or venoarterial ECMO. Hemodynamic failure was diagnosed upon ICU admission and persisted in the patients recruited for at least 48 hours after admission. Exclusion criteria were a history of gastrointestinal (GI) ischemia or aortic dissection involving the mesenteric vessels.
Hemodynamic Monitoring
In the first few ICU days, patients underwent advanced hemodynamic monitoring of arterial pressure (MAP), central venous pressure (CVP), and cardiac index (CI, using a Swan-Ganz catheter). Using these data, we determined the lowest daily MAP/CI and the highest daily CVP, eliminating erroneous measurements. After invasive monitoring, MAP was noninvasively measured every hour. As for the invasive recordings, the lowest daily MAP was recorded once erroneous measurements were eliminated. Vasoactive and inotropic drug doses were calculated every hour in µg/kg/min. From these data, the highest daily dose was recorded for each patient. Blood lactate was determined every 8 hours and the daily peak recorded for each patient.
Nutrition Support
Nutrition support was given in the form of EN according to the protocol established at our ICU. 25 Based on the results of metabolic studies, 19 23 Enteral access was nasogastric. Feeds were adjusted to gradually achieve 100% of the energy target in daily 25% steps over the first 4 days. No prokinetic agents were routinely used. The enteral formulas prescribed by the attending physician were Jevity (Abbott Nutrition, North Chicago, IL), Impact (Nestlé SA, Vevey, Switzerland), Isosource Protein (Nestlé), Novasource GI control (Nestlé), or Novasource Diabet Plus (Nestlé). EN was started after checking the patient's GI tolerance of fluids (a gastric residual volume [GRV] <200 mL in response to 100 mL of water given every 3 hours by the nasogastric route). Feeding solutions were delivered over 23 hours by continuous pumping. GRV was checked every 6 hours on the first day of EN, every 12 hours on the second day, and on a daily basis thereafter. GRV was described as high when >500 mL was obtained in each assessment. 25 To reduce the risk of pulmonary aspiration and/or ventilation-associated pneumonia, the patient's head was elevated >30° from the horizontal during enteral feeding. Abdominal distention was defined as a change in the abdomen detected in a physical examination and was usually an increase in abdominal cavity size relative to that recorded in the pre-EN examination. Regurgitation was defined as the presence of EN feed in the oral cavity or oropharynx, as well as its spontaneous drainage by the oral and/or nasal route. EN-related diarrhea was defined as 5 or more liquid stools in 24 hours or more than two 1000-mL stool volumes, each deposited over a 24-hour period. Bronchoaspiration was defined as the presence of respiratory secretions of similar characteristics to the prescribed EN feed, confirmed by the glucose-oxidase technique in tracheal secretion. Constipation was defined as a lack of bowel movements in 7 days from the onset of EN or for 3 days in the first week of admission.
All possible complications were assessed daily by the attending physician and recorded in the data collection forms.
Patient Follow-up
Patients were followed from the start to day 28 of EN. The variables examined are described in Table 1 .
According to our institutional review board guidelines, informed consent is not required for this type of study. The database used was maintained by the principal researcher (J.L.F.L.). All data were confidential and encoded so that only the research team members were aware of patient identities.
Statistical Analysis
Data are provided as means and their corresponding 95% confidence intervals (CIs) for continuous variables and as absolute and relative frequencies for categorical variables. Mean energy delivered, nutrition tolerance, and blood lactate levels during the course of EN are graphically represented for the entire study sample. Qualitative variables in contingency tables were compared using the χ 2 or Fisher exact tests. The Wilcoxon-Mann-Whitney test or Student t test, as appropriate, was used to compare ordinal and continuous measurement distributions. To account for subject effects on repeat measurements that could lead to bias (eg, blood lactate, cardiac index, or Sequential Organ Failure Assessment [SOFA] score), a mixed-effects regression model was constructed using 2-level data for observations repeated over time (level 1) nested within patients (level 2). We estimated the mean and 95% confidence interval of the dependent variable (eg, SOFA or blood lactate) measured over time, using the model with or without correction for patient characteristics (ICU stay, need for IABP/ mechanic support, and complications). Because of the limited sample size, a multivariate analysis to identify variables independently associated with EN efficacy and safety was not considered appropriate. All statistical tests were performed using SAS software (SAS Institute, Inc, Cary, NC). Our hospital's Unit of Research Support was responsible for the statistical treatment of data.
Results

Patient Characteristics
In total, 642 consecutive post-cardiac surgery patients recruited over a period of 17 months were examined (for characteristics, see Table 2 ). Of these, 37 (5.8%) met the inclusion criteria ( Figure 1 ). Participants showed high severity scores (means of 37 and 8 in the Simplified Acute Physiology Score II [SAPS II] and SOFA, respectively), a high incidence of early multiorgan dysfunction (failure of 2 or more organ systems in the first 48 hours), and prolonged ICU stay (mean 25 days; in 81%, ICU stay was >7 days). Valve replacement surgery was the most common surgical procedure.
Hemodynamic Status
As indicated in the Methods section, all patients had hemodynamic failure during the first 48 hours of the ICU stay (see Table  3 ), which is when EN was started in most patients (n = 36, 97.3%). Moreover, in this period, a significant proportion of the patients was severely hemodynamically unstable (3 vasoactive drugs were required in 38% of the patients, 4 drugs in 24%, and 4 vasoactive drugs plus mechanical assistance in 16%). 
Efficacy of EN Support
EN was the only form of nutrition support given in 33 (89%) patients (see Table 4 and Figure 2 ). In 4 patients, supplementary parenteral nutrition (PN) was needed to achieve caloric goals. EN was initiated on the second day after ICU admission in 36 
Safety of EN Support
EN-related complications were observed in 23 patients (62%), although no serious GI complications or clinical signs of mesenteric ischemia were recorded (see Table 5 ). The most common complication was constipation (46%, n = 17). In 1 patient with GI bleeding, a diagnosis of ischemic colitis attributed to prior vascular disease was made upon colonoscopy.
Patient Groups of Special Interest
Short (≤7 days) and long (>7 days) ICU stays for patients (see Table 6 and Figure 2c ). In the short-stay group, the most AMI, acute myocardial infarction; CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; CRRT, continuous renal replacement therapy; EUROSCORE, European System for Cardiac Operative Risk Evaluation; ICU, intensive care unit; MODS, multiple organ dysfunction syndrome; SAPS II, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment. Mechanical circulatory support included intra-aortic balloon pump, ventricular assist device, or extracorporeal membrane oxygenation (ECMO). "Short stay" refers to patients whose ICU stay was ≤7 days. "Long stay" refers to patients spending > 7 days in the ICU. frequently performed surgery was valve replacement (n = 3, 42.9%), followed by coronary artery bypass graft (n = 2, 28.6%). In contrast, patients in the long-stay group were those with more serious conditions undergoing more complex surgical procedures such as heart transplant (n = 4, 13.3%) or ECMO/ventricular assist device placement on ICU admission due to cardiogenic shock (n = 6, 20%). No significant difference in illness severity scores or ICU mortality was observed between the 2 groups. However, the long-stay patients showed a significantly higher rate of complications attributable to EN. None of these complications were serious, and most did not require EN discontinuation or interruption. In addition, a greater energy deficit and a lower nutrition tolerance were observed in this group of patients.
Patients requiring IABP/ECMO or a ventricular assist
device. No significant differences in the calories administered by the enteral route, energy balance, or nutrition tolerance were observed between patients requiring or not requiring mechanical assistance. Those requiring mechanical assistance showed a higher rate of EN-related complications (82%). These minor complications were managed according to our EN protocol.
Patients with EN-related complications.
No significant differences in illness severity scores, mortality, or hemodynamic variables were detected in patients with or without EN-related complications.
Discussion
The findings of our study indicate that early EN is feasible in postoperative cardiac surgery patients with hemodynamic failure. We observed that early EN was effective and safe, even in the more severely ill and unstable patients included in our study (those requiring ECMO, IABP, or mechanical assistance). In our experience, the patients in our cardiac surgery ICU normally show good EN tolerance. The main problem generally encountered is an inability to achieve the established nutrition target. This target was attained in only 40% of our study patients, leading to a high cumulative energy deficit. Berger et al 21 also observed that EN support usually leads to hypocaloric feeding in post-cardiac surgery patients. The same conclusion was reached in 2 recent reviews. 23, 24 The causes of underfeeding in patients receiving EN are multiple. Our cautious approach to attaining the preset energy target was, in our opinion, the main cause of the undernutrition observed in our patients. The practice of supplementary PN in critically ill patients is controversial, 21, 23, 24, 32, 33 and we have observed its limited use in our cardiac surgery ICU. In effect, volume intake restriction in cardiac surgery patients showing hemodynamic instability is common practice. When we compared our shortstay (≤7 days) and long-stay (>7 days) ICU patients (Table 6) , it was noted that although nutrition tolerance in the short-stay group was not a problem, the energy target was not generally reached. This can be explained by our cautious approach to EN diet adjustment and attempts at oral feeding. Such attempts are frequently an inefficient source of calories. 34 In the long-stay ICU group, a higher rate of complications led to a significant reduction in energy delivery and broadly negative cumulated energy balances. Maybe this subgroup of patients might especially benefit from supplementary PN.
According to the EN safety-related variables assessed (Table 5) , no patient experienced serious GI complications. There was a single case of GI bleeding due to ischemic colitis detected and confirmed by colonoscopy. Constipation was the most frequent complication and perhaps indicates a need for preventive treatment in these patients. In the short-stay ICU patients, this complication was less common (Table 6 ). In general, the complications detected were mild and could be resolved by interrupting EN and/or reducing the infusion rate.
At this point, we should stress that clinical, analytical, and radiological follow-up of these patients during early EN is critical. Nutrition support must be performed according to a previously established protocol. Moreover, careful and repeated monitoring of warning signs of intestinal ischemia such as a high GRV, abdominal distention, intra-abdominal pressure >15 mm Hg, oliguria, leukocytosis, hemodynamic instability with lactic acidosis, or a radiographic finding of dilated, thickened bowel loops is required. 23, 35 According to U.S. and European guidelines, 11, 12 early EN in critically ill postoperative cardiac surgery patients is controversial. The pathophysiology of splanchnic circulation is complex in conditions of both hemodynamic stability and instability. The presence of nutrients in the gut lumen is important for normal gut structure and function. In hemodynamically stable individuals, this increases splanchnic blood flow known as "postprandial hyperemia." 36 Shock induces intense visceral vasoconstriction, decreasing oxygen delivery and increasing tissue oxygen consumption, eventually leading to mesenteric ischemia. 37 However, effects on the splanchnic circulation are complex and vary with the etiology of shock. Furthermore, the vasoactive and inotropic support used in these patients affects the GI tract and splanchnic microcirculation. [38] [39] [40] There is evidence that lowered splanchnic blood flow in response to cardiogenic shock may persist even after hemodynamic variables have normalized, suggesting a role played by other factors in regulating blood flow to the tissues. This evidence has changed our concept of cardiogenic shock from being essentially a cardiac problem to being a microcirculatory disease. 24, [41] [42] [43] In effect, microcirculatory alterations have been related to an increase in mortality in humans. 43 In animal models of shock, reduced splanchnic blood flow has been linked to bowel ischemic injury, bacterial translocation, and multiorgan dysfunction. 44, 45 It may thus be hypothesized that interventions able to improve splanchnic blood flow will play a protective role. 35, 46 This has been demonstrated in animal models. [13] [14] [15] [16] [17] The findings of studies conducted in critically ill patients have reinforced the hypothesis of a beneficial effect of EN support in conditions of circulatory compromise. In a study performed in postoperative cardiac surgery patients in 2000, Berger et al 18 observed that the intestinal tract maintains its absorptive capacity, even when there is hemodynamic failure. One year later, Revelly et al 19 reported beneficial effects on hemodynamic parameters of EN in 9 postoperative cardiac surgery patients. This study was followed by an observational study including 73 post-cardiac surgery patients by Kesek et al 20 in which initiating EN within 72 hours of ICU admission was found to be feasible and resulted in no serious complications. However, hemodynamic instability and illness severity were not quantified. Two years later in 2005, Berger et al 21 published the results of a prospective, descriptive study including 70 patients with circulatory failure, 25.7% of whom needed mechanical support. Patients were similarly assessed as in our study, although hemodynamic monitoring was less thorough. These authors reported that EN was possible in most patients and not related to serious complications, although energy delivery was often insufficient, as observed in our study. More recently, Lukas et al 22 addressed the tolerability and safety of EN in 48 patients with respiratory or hemodynamic failure requiring ECMO. Nutrition tolerance was 68%, and no serious complications were associated with nutrition support. In a report of our initial experience with early EN in 7 patients requiring venoarterial ECMO for severe hemodynamic failure after cardiac surgery, 47 we were able to conclude that the procedure was possible and safe in these patients.
Our study has several limitations. Being an observational, single-center study with no control group conducted on a small sample size, we are aware that an intervention clinical trial is needed to confirm its findings. Although we included patients undergoing different types cardiac surgery procedures, they all showed a complicated postoperative course, including a high mortality rate, prolonged ICU stay in most cases, and a high rate of multiorgan dysfunction. The patients also had in common hemodynamic failure at least within the first 48 hours of the ICU stay. In our opinion, this patient population is highly representative of that generally observed in a cardiac surgery ICU.
Conclusions
Our findings indicate that early EN in critically ill post-cardiac surgery patients with hemodynamic failure is feasible, safe, and not related to any serious complications. However, it is difficult to meet the nutrition requirements of patients when this is the only feeding route. These observations highlight the need for an established EN protocol including daily monitoring of energy delivery and energy balance to achieve preset calorie targets. These high-risk patients also need to be carefully monitored for warning signs of gut ischemia. 
